Skip Navigation

University of Oklahoma Joins National Cancer Institute’s Global Cancer Prevention Effort

NEWS
Bui with leaders from the Lao National Center for HIV/AIDS and STI.
Bui, second from the left, with leaders from the Lao National Center for HIV/AIDS and STI

University of Oklahoma Joins National Cancer Institute’s Global Cancer Prevention Effort


By

Josh DeLozier

joshdelozier@ou.edu

Date

Nov. 21, 2024

NORMAN, OKLA. – People with HIV tend to use tobacco at more than twice the rate of the general population, and smoking is among the leading causes of illness and death among people with HIV. Additional data from the National Center for HIV/AIDS and STIs of Laos indicate that 61% to 80% of men with HIV in that country smoke cigarettes.

Thanh Bui, M.D., an associate professor in the Department of Family and Preventive Medicine at the University of Oklahoma College of Medicine and member of the OU Health Stephenson Cancer Center, is leading an effort to reduce rates of cancer illness and death of tobacco users with HIV in Laos. The researchers will implement a mobile health-based intervention to help HIV-positive smokers quit smoking and obtain cancer screenings. 

“Reducing tobacco use is one of the most important methods to prevent cancer, cardiovascular disease and other non-communicable diseases that lead to high morbidity,” he said. “For people with HIV, their immunity is compromised and they are, therefore, more likely to develop cancer. That’s why we’re specifically targeting this population.”

The U.S. National Cancer Institute is expanding its efforts to prevent cancers worldwide, especially in low- and middle-income countries. Bui, who originally hails from Vietnam and earned a master’s degree in global health and a doctoral degree in health promotion sciences, is also working on projects in Cambodia and understands the impact this research can have on this region.

A mock-up of mobile phone notifications.
Mobile phone notification simulation.

Bui’s team will deploy a smartphone application to provide a fully automated, personalized, interactive tobacco cessation treatment program for this population. According to the United Nations’ International Telecommunication Union and the Lao government’s Statistics Bureau, mobile phone ownership in Laos is between 103% and 118%. Knowing this, they will focus their efforts on implementing the AAC strategy at HIV clinics: Ask people with HIV if they smoke, advise them to quit and connect them to their mobile health intervention app.

“Here at the OU Health Stephenson Cancer Center, the Mobile Health Shared Resource offers a platform for mobile health that allows individual researchers to design studies and deploy them through their targeted app,” he said. “All the intervention messages for a six-month treatment period are pre-loaded into the app, so once it is installed, the user doesn’t even need an internet connection for the app to work.”

Through the app, users will answer questions about their feelings of distress or self-confidence along with questions about their phase of quitting. The app will then deliver daily, individualized messages and tips to help guide them through the quitting process or maintain cessation and avoid relapse.

“Our goal is to see 20% to 40% of users in Laos successfully quit with the help of our mobile intervention,” he said. “We hope that nearly all the HIV clinics in Laos implement our ACC strategy. Doing so will help a lot of people with HIV quit smoking and live longer.”

As the study continues, Bui’s team will examine the associated costs and cost effectiveness of this intervention program. Because their mobile health app functions autonomously and requires minimal human involvement, he believes that it will be both scalable and affordable for governments to implement.

“Many developing countries like Laos can target policies that reduce tobacco use. These include putting pictorial health warnings on packages or reducing mass marketing of tobacco products,” he said. “But they have a harder time providing widely available tobacco treatment programs at a national level due to the required human resources and associated costs. Hopefully, mobile health options like ours can help reduce tobacco use and save lives.”

About the project

The project, “Implementing Sustainable mobile health Technology to Optimize smoking cessation Program for Lao people with HIV (I-STOP),” is funded by an expected $3,187,275 million grant from the National Cancer Institute of the U.S. National Institutes of Health, award no. U01CA294811, with additional support from the Oklahoma Tobacco Settlement Endowment Trust. Bui, DrPH, also received a Presbyterian Health Foundation Research Support Award that provides stipend support for a senior doctoral graduate student. The project began in Aug. 2024 and is expected to conclude in July 2029.

About the University of Oklahoma

Founded in 1890, the University of Oklahoma is a public research university located in Norman, Oklahoma. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. For more information about the university, visit www.ou.edu.


Recent News

Research
December 20, 2024

Benbrook Appointed Associate Director for Translational Research at OU Health Stephenson Cancer Center

Doris Benbrook, Ph.D., a Presbyterian Health Foundation Presidential Professor at the University of Oklahoma College of Medicine, has been named Associate Director for Translational Research at OU Health Stephenson Cancer Center, the only National Cancer Institute-Designated Cancer Center in Oklahoma.


Campus & Community
December 20, 2024

Harold Hamm Diabetes Center at the University of Oklahoma announces new deputy director.

The Harold Hamm Diabetes Center at the University of Oklahoma Health Sciences will gain a new deputy director, Matthew Potthoff, Ph.D., effective January 1. Potthoff will also hold the title of Harold Hamm Endowed Chair in Clinical Diabetes Research and professor of biochemistry and physiology, with a secondary appointment in the division of neurology in the OU School of Medicine.


Campus & Community
December 18, 2024

American Society of Hematology Recognizes Two OU Health Sciences Faculty

James George, M.D., and Jennifer Holter-Chakrabarty, M.D., were recognized by the American Society of Hematology (ASH) during its annual meeting Dec. 7-10.